Skip to main content
Fig. 1 | Alzheimer's Research & Therapy

Fig. 1

From: Novel antibodies detect additional α-synuclein pathology in synucleinopathies: potential development for immunotherapy

Fig. 1

IHC analysis of characteristic α-Syn aggregates in synucleinopathies. Representative images of Lewy bodies, Lewy neurites and dystrophic neurites in LB diseases (PD and DLB), and glial cytoplasmic inclusions (GCI) and glial nuclear inclusion (GNI) in cases of MSA are shown for IGG-1, IGG-2, IGG-3 and NOV. Top panel shows lack of α-Syn immunoreactivity in control cases for each antibody. Scale bar = 10 μm

Back to article page